Pioneering Innovation in Schizophrenia Diagnosiss
VOLABIOS is a groundbreaking European research project under the Horizon Europe framework, dedicated to transforming the way schizophrenia is diagnosed and monitored. Combining cutting-edge technologies, interdisciplinary collaboration, and patient-centered solutions, VOLABIOS aims to address the global challenge of diagnosing and managing this complex mental health condition.
HOURS & PRICING
We look forward to seeing you!
Our Purpose
We strive for a future where schizophrenia is detected early, diagnosed accurately, and treated effectively, enhancing the quality of life for millions worldwide. Through innovation, we develop advanced, non-invasive diagnostic tools to improve precision and reduce errors.
By fostering collaboration among experts from 18 organizations across eleven European countries, VOLABIOS is not only advancing early schizophrenia (SZ) diagnostics but also delivering a suite of impactful solutions. These include cutting-edge portable technologies for real-time diagnosis using VOC biomarkers, a Clinical Decision Support System (CDSS), and a mobile health application tailored to patients and clinicians.
For healthcare systems, these innovations promise earlier and more accurate diagnoses, reduced hospitalization rates, lower long-term treatment costs, and integration into national public health frameworks.
Patients benefit from earlier interventions, improved quality of life, reduced stigma, and the empowerment to manage their own mental health through co-designed digital tools.
Meanwhile, researchers gain access to a rich multi-omics database, standardized biobank resources, and scalable tools for international collaborations, accelerating innovation in schizophrenia research and treatment
Our Approach
Multi-Omics Analysis
Volatolomics
Artificial Intelligence
portable spectrometry devices
Living Labs
Interdisciplinary Collaboration
For more details, explore our glossary page for clear explanations of all key terms used in VOLABIOS.
The VOLABIOS consortium & key objectives
VOLABIOS is built on a multidisciplinary consortium comprising leading academic institutions, research organizations, renowned clinical centers, healthcare providers, industry experts, and policymakers. An advisory board of internationally recognized experts in psychiatry, neuroscience, and public health ensures practical application and improved patient outcomes.
The project aims to reduce diagnostic errors (improving accuracy by 30%), accelerate diagnosis for earlier intervention and optimized treatment, and create an open-access database to support future research and innovation in mental health.
WHAT SPEAK PEOPLE
“I greatly appreciate the communication on the very hard process, what we needed to do in terms of providing good samples, what to expect. Novalab laboratory provided tests what we needed in terms of laboratory certification that we can use with our customers.”
“I greatly appreciate the communication on the very hard process, what we needed to do in terms of providing good samples, what to expect. Novalab laboratory provided tests what we needed in terms of laboratory certification that we can use with our customers.”
“I greatly appreciate the communication on the very hard process, what we needed to do in terms of providing good samples, what to expect. Novalab laboratory provided tests what we needed in terms of laboratory certification that we can use with our customers.”